| Gene symbol | CD80 | Synonyms | B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q13.33 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD80 molecule | ||||
| Gene symbol | CD86 | Synonyms | B7-2, B7.2, B70, CD28LG2, LAB72 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q13.33 | dbXrefs | |
| Description | CD86 molecule | ||||
| Gene symbol | CD274 | Synonyms | B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1, hPD-L1 | Type of gene | protein-coding |
| Chromosome | 9 | Map location | 9p24.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | CD274 molecule | ||||
| GTO ID | GTC1696 |
| Trial ID | NCT03060343 |
| Disease | Lung Non-Small Cell Carcinoma |
| Altered gene | PD-L1|CD80|CD86 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PD-L1/CD80/CD86 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC) |
| Year | 2017 |
| Country | China |
| Company sponsor | Yu Fenglei |
| Other ID(s) | Z-NSCLC-01 |
| Cohort 1 | |||||||||||
|
|||||||||||